Sinopharm Group (Germany) Market Value
| X2S Stock | 2.48 0.01 0.40% |
| Symbol | Sinopharm |
Sinopharm Group 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Sinopharm Group's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Sinopharm Group.
| 09/24/2024 |
| 01/22/2025 |
If you would invest 0.00 in Sinopharm Group on September 24, 2024 and sell it all today you would earn a total of 0.00 from holding Sinopharm Group Co or generate 0.0% return on investment in Sinopharm Group over 120 days. Sinopharm Group is related to or competes with SEI INVESTMENTS, ALEFARM BREWING, MidCap Financial, Dairy Farm, Hanison Construction, Hitachi Construction, and PennantPark Investment. More
Sinopharm Group Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Sinopharm Group's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Sinopharm Group Co upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 1.88 | |||
| Information Ratio | 0.0349 | |||
| Maximum Drawdown | 7.75 | |||
| Value At Risk | (2.75) | |||
| Potential Upside | 2.89 |
Sinopharm Group Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Sinopharm Group's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Sinopharm Group's standard deviation. In reality, there are many statistical measures that can use Sinopharm Group historical prices to predict the future Sinopharm Group's volatility.| Risk Adjusted Performance | 0.0522 | |||
| Jensen Alpha | 0.0737 | |||
| Total Risk Alpha | 0.0327 | |||
| Sortino Ratio | 0.0327 | |||
| Treynor Ratio | 0.1635 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Sinopharm Group's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Sinopharm Group Backtested Returns
Currently, Sinopharm Group Co is moderately volatile. Sinopharm Group owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.0556, which indicates the firm had a 0.0556 % return per unit of risk over the last 3 months. We have found twenty-seven technical indicators for Sinopharm Group Co, which you can use to evaluate the volatility of the company. Please validate Sinopharm Group's Semi Deviation of 1.6, coefficient of variation of 1797.62, and Risk Adjusted Performance of 0.0522 to confirm if the risk estimate we provide is consistent with the expected return of 0.0979%. Sinopharm Group has a performance score of 4 on a scale of 0 to 100. The entity has a beta of 0.54, which indicates possible diversification benefits within a given portfolio. As returns on the market increase, Sinopharm Group's returns are expected to increase less than the market. However, during the bear market, the loss of holding Sinopharm Group is expected to be smaller as well. Sinopharm Group right now has a risk of 1.76%. Please validate Sinopharm Group semi variance, and the relationship between the maximum drawdown and daily balance of power , to decide if Sinopharm Group will be following its existing price patterns.
Auto-correlation | -0.07 |
Very weak reverse predictability
Sinopharm Group Co has very weak reverse predictability. Overlapping area represents the amount of predictability between Sinopharm Group time series from 24th of September 2024 to 23rd of November 2024 and 23rd of November 2024 to 22nd of January 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Sinopharm Group price movement. The serial correlation of -0.07 indicates that barely 7.0% of current Sinopharm Group price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.07 | |
| Spearman Rank Test | 0.22 | |
| Residual Average | 0.0 | |
| Price Variance | 0.01 |
Sinopharm Group lagged returns against current returns
Autocorrelation, which is Sinopharm Group stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Sinopharm Group's stock expected returns. We can calculate the autocorrelation of Sinopharm Group returns to help us make a trade decision. For example, suppose you find that Sinopharm Group has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Sinopharm Group regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Sinopharm Group stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Sinopharm Group stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Sinopharm Group stock over time.
Current vs Lagged Prices |
| Timeline |
Sinopharm Group Lagged Returns
When evaluating Sinopharm Group's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Sinopharm Group stock have on its future price. Sinopharm Group autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Sinopharm Group autocorrelation shows the relationship between Sinopharm Group stock current value and its past values and can show if there is a momentum factor associated with investing in Sinopharm Group Co.
Regressed Prices |
| Timeline |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Sinopharm Stock Analysis
When running Sinopharm Group's price analysis, check to measure Sinopharm Group's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sinopharm Group is operating at the current time. Most of Sinopharm Group's value examination focuses on studying past and present price action to predict the probability of Sinopharm Group's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sinopharm Group's price. Additionally, you may evaluate how the addition of Sinopharm Group to your portfolios can decrease your overall portfolio volatility.